{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":" \u2764\ufe0f\u200d\ud83e\ude79 Sensitized, Desensitized, Transplanted: CAR-T Opens a New Door in Kidney Transplantation","description":"\ud83e\uddec Groundbreaking NEJM report! Two highly sensitized kidney transplant candidates (cPRA ~99.995\u201399.998%) underwent successful transplantation after dual CD19- and BCMA-targeted CAR-T therapy. \ud83c\udfaf &amp;nbsp; Rather than simply removing antibodies, investigators targeted the cells that produce them\u2014memory B cells and plasma cells. The result? Profound reduction in anti-HLA antibodies, successful transplantation, and no donor-specific antibody rebound during follow-up. \ud83d\ude80 &amp;nbsp; This study expands the horizon of CAR-T beyond oncology and may herald a new era in transplant immunology. &amp;nbsp; \ud83d\udcd6 NEJM 2026: Bhoj et al. #KidneyTransplant #CART #TransplantImmunology #PrecisionMedicine #MedicalInnovation #MedEd \ud83e\ude7a ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41554585\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/202674290"}